Biotech Startup Scientific Content Creation

Metabolomics is a powerful tool used for clinical research, diagnostics, and personalized medicine among many other fields. Fluidome reduces the complexity of metabolomics research with our custom-designed kits including consumables and software which make metabolomics workflows quicker, easier, and more accessible. We would like students to help us with creating scientific content that is aligned with our vision, mission, and sector. Ultimately, you will be working on content creation for our organization, including video, social media, and other educational materials that we can use as go-to marketing tools.

Biotech Startup Competitor Analysis

Metabolomics is a powerful tool used for clinical research, diagnostics, and personalized medicine among many other fields. Fluidome reduces the complexity of metabolomics research with our custom-designed kits including consumables and software which make metabolomics workflows quicker, easier, and more accessible. We would like students to help us with analyzing similar products on the market and determining our market fit. Additionally, the student will perform a unit cost analysis of our products to determine an appropriate pricing strategy for our target markets.

Grant and Pitch Preparation for Re:Pair Genomics Inc.

Re:Pair Genomics Inc., a biotech startup, is seeking to secure funding to advance its innovative solutions in the genomics field. The project aims to identify potential non-dilutive funding sources, including grants and pitch competitions, that align with the company's mission and objectives. The team will conduct research to compile a list of suitable funding opportunities and analyze the requirements for each. Additionally, the project involves assisting in the preparation of application materials, ensuring they are tailored to meet the specific criteria of each funding source. This project provides an opportunity for learners to apply their research, writing, and analytical skills in a real-world context, while gaining insight into the biotech industry's funding landscape.